Catalyst Pharmaceuticals, Inc.

MORGAN STANLEY CPRX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

2,933,399

Value ($000)

68,466

Weight

0.0%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	68,466	0.0%	2,933,399	12/31/2025
2025 Q3	11/14/2025	36,319	0.0%	1,843,624	9/30/2025
2025 Q2	8/14/2025	69,082	0.0%	3,183,523	6/30/2025
2025 Q1	5/15/2025	58,068	0.0%	2,394,555	3/31/2025
2024 Q4	5/15/2025	43,578	0.0%	2,088,050	12/31/2024
2024 Q3	5/14/2025	36,247	0.0%	1,823,274	9/30/2024
2024 Q2	5/14/2025	15,686	0.0%	1,012,679	6/30/2024
2024 Q1	5/15/2024	28,674	0.0%	1,798,856	3/31/2024
2023 Q4	2/13/2024	32,973	0.0%	1,961,539	12/31/2023
2023 Q3	11/15/2023	10,674	0.0%	913,095	9/30/2023
2023 Q2	8/14/2023	12,016	0.0%	894,068	6/30/2023
2023 Q1	5/15/2023	23,681	0.0%	1,428,313	3/31/2023
2022 Q4	2/14/2023	32,316	0.0%	1,737,403	12/31/2022
2022 Q3	11/14/2022	20,069	0.0%	1,564,145	9/30/2022
2022 Q2	10/27/2022	10,174	0.0%	1,451,262	6/30/2022
2022 Q1	10/27/2022	10,291	0.0%	1,241,326	3/31/2022
2021 Q4	2/14/2022	1,794	0.0%	265,108	12/31/2021
2021 Q3	11/15/2021	1,175	0.0%	221,600	9/30/2021
2021 Q2	8/23/2021	1,985	0.0%	345,417	6/30/2021
2021 Q1	5/17/2021	422	0.0%	91,514	3/31/2021
2020 Q4	2/16/2021	555	0.0%	166,175	12/31/2020
2020 Q3	11/13/2020	8,257	0.0%	2,780,077	9/30/2020
2020 Q2	8/14/2020	13,028	0.0%	2,820,035	6/30/2020
2020 Q1	5/26/2020	10,443	0.0%	2,712,629	3/31/2020
2019 Q4	2/14/2020	10,737	0.0%	2,863,325	12/31/2019
2014 Q1	5/13/2014	7	0.0%	3,161	3/31/2014
2013 Q4	2/13/2014	17	0.0%	8,701	12/31/2013